Palomino Laboratories (PALX) Payables (2022 - 2025)

Palomino Laboratories has disclosed Payables across 4 years of filings, most recently posting $55687.0 for Q4 2025.

• Payables for Q4 2025 came in at $55687.0, up 765.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $55687.0 (up 765.92% YoY), and the FY2025 annual result was $55687.0, up 765.92% from the prior year.
• Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $177004.0 in Q3 2024 to a low of $6431.0 in Q4 2024.
• The 4-year median for Payables is $55687.0 (2025), against an average of $63031.8.
• Peak annual rise in Payables reached 765.92% in 2025, while the deepest fall reached 65.56% in 2025.
• Palomino Laboratories' Payables stood at $12804.0 in 2022, then dropped by 21.45% to $10058.0 in 2023, then slumped by 36.06% to $6431.0 in 2024, then jumped by 765.92% to $55687.0 in 2025.
• The last three Payables figures came in at $55687.0 (Q4 2025), $60952.0 (Q3 2025), and $60781.0 (Q2 2025), per Business Quant data.